• Welcome to Innova Vascular

    Innova Vascular, Inc. Receives U.S. (FDA) 510(k) Clearance for its Laguna Clot Retriever™ System and its Malibu Aspiration Catheter™ System

    View Press Release
  • Welcome to Innova Vascular

    Developing Innovative Minimally Invasive Device Solutions For Treating Vascular Thromboembolism

    Contact Us

About Innova Vascular

Innova Vascular is engaged in developing innovative medical devices for treating vascular disease using minimally invasive approach. Innova Vascular is located in beautiful southern California, which is a hub for medical device development for vascular disease. The area benefits from the availability of top engineering talent pool and leading academic institutions such as Cal Tech, UCLA, UCSD, UC Irvine, USC and others within a short drive.
  • Innova Vascular Exterior 2
  • Innova Vascular Interior
  • Innova Vascular Product
Dr. Sanjay Shrivastava

Leadership

Dr. Sanjay Shrivastava is the founder and CEO of Innova Vascular.  Sanjay has been involved in developing, commercializing, evaluating, and acquiring medical devices for over 20 years.  During his career, Sanjay has held leadership positions at leading medical device companies including senior director, business development at Johnson & Johnson, vice president, upstream marketing and strategy at BTG, plc. (acquired by Boston Scientific Corporation), director global marketing at Medtronic, and director, research & development at Covidien/ev3 (merged with Medtronic). Sanjay cofounded BlackSwan Vascular–a clinical stage medical device startup company, where he serves on the board of directors. In 2020, BlackSwan Vascular, Inc. entered in a strategic alliance with Sirtex Medical.  Additionally, Sanjay serves as a member of the board of directors at enVVeno Medical Corporation (Nasdaq: NVNO). 

Sanjay holds over 30 issued US patents and numerous international patents in medical devices and has edited two books including one titled “Medical Device Materials” published by ASM International.  He was named among 100 Notable People in Medical Device Industry by the prestigious MD&DI (Medical Devices and Diagnostics Industry) magazine.  He has been an invited speaker at clinical, business, and engineering conferences to speak about medical device innovation and commercialization.  Sanjay holds a doctorate in materials science and engineering from the University of Florida and a bachelor’s from the Indian Institute of Technology. 

Board of Directors

Dr. Owen O’Niell

Orthopedic Surgeon & President
Twin Cities Orthopedics

Scott Ward

(Board Observer)

Chairman, President and Chief Executive Officer
Cardiovascular Systems, Inc.

 

Dr. Sanjay Shrivastava

Chief Executive Officer
Innova Vascular, Inc.

Innova Vascular Press Release

Innova Vascular Earns FDA Clearance for Two New Thrombectomy Devices: Laguna Clot Retriever™ System and Malibu Aspiration Catheter™ System

IRVINE, Calif, June 7, 2023 /PRNewswire/ — Innova Vascular, Inc. announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Laguna Clot Retriever™ System and its Malibu Aspiration Catheter™ System for use in the peripheral vasculature. The two new devices are collectively known as the Laguna Thrombectomy System.

Read More
Innova Vascular Press Release

Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices

ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today it has partnered with Innova Vascular, Inc. (Innova) to develop a full line of novel thrombectomy devices.

Read More

Contact us

If you have an interest in being part of our journey as employees, suppliers, consultants or in any other capacity, please email us.

info@innovavascular.com

innova Vascular

Innova Vascular, Inc. 15375
Barranca Parkway, B-101
Irvine, CA 92618